Showing results (71-80 of 166) with videos related to

Sort By:
Pageof 17
Diabetes, Obesity & Metabolism|August 1, 2024
Estimated glomerular filtration rate slope and risk of primary and secondary major adverse cardiovascular events and heart failure hospitalization in people with type 2 diabetes: An analysis of the EXSCEL trialAbderrahim Oulhaj, Faisal Aziz, Abubaker Suliman, et al.
Scientific Reports|July 2, 2024
Impact of baseline ECG characteristics on changes in cardiac biomarkers and echocardiographic metrices after acute myocardial infarction treated with EmpagliflozinMartin Benedikt, Faisal Aziz, Thomas Fröschl, et al.
International Journal of Molecular Sciences|November 14, 2023
Changes in Lipoprotein(a) Levels in People after ST Elevation Myocardial Infarction-The STEMI-Lipids StudyCaren Sourij, Faisal Aziz, Sarah Krappinger, et al.
Frontiers in Cardiovascular Medicine|July 22, 2022
Effects of BNP and Sacubitrilat/Valsartan on Atrial Functional Reserve and Arrhythmogenesis in Human MyocardiumUwe Primessnig, Peter M Deißler, Paulina Wakula, et al.
Antioxidants (Basel, Switzerland)|November 11, 2022
Myeloperoxidase as a Potential Biomarker of Acute-Myocardial-Infarction-Induced Depression and Suppression of the Innate Immune SystemAndreas Baranyi, Dietmar Enko, Andreas Meinitzer, et al.
European Journal of Clinical Investigation|June 8, 2020
Ticagrelor and prasugrel are independent predictors of improved long-term survival in ACS patientsGloria M Gager, Bernd Jilma, Max-Paul Winter, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|May 26, 2023
Effects of empagliflozin in women and men with acute myocardial infarction: An analysis from the EMMY trialCaren Sourij, Faisal Aziz, Norbert J Tripolt, et al.
European Journal of Psychotraumatology|June 9, 2021
Assessment of trimethylamine N-oxide (TMAO) as a potential biomarker of severe stress in patients vulnerable to posttraumatic stress disorder (PTSD) after acute myocardial infarctionAndreas Baranyi, Dietmar Enko, Dirk von Lewinski, et al.
Cardiovascular Diabetology|July 5, 2023
Impact of the SGLT2-inhibitor empagliflozin on inflammatory biomarkers after acute myocardial infarction - a post-hoc analysis of the EMMY trialMartin Benedikt, Harald Mangge, Faisal Aziz, et al.
Heart (British Cardiac Society)|July 30, 2013
Bile acids induce arrhythmias in human atrial myocardium--implications for altered serum bile acid composition in patients with atrial fibrillationPeter P Rainer, Uwe Primessnig, Sandra Harenkamp, et al.
Pageof 17